Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Credit Suisse Ag | SLVO | 31. oct 2024 | 82.65 | -1.71 |
Credit Suisse Ag | GLDI | 31. oct 2024 | 158.64 | -0.50 |
Credit Suisse Asset Management Income Fund | CIK | 31. oct 2024 | 2.95 | -1.01 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | 31. oct 2024 | 65.21 | +1.92 |
Credit Suisse High Yield Bond Fund | DHY | 31. oct 2024 | 2.15 | +0.47 |
Credo Technology | CRDO | 31. oct 2024 | 37.70 | -6.06 |
Crescent Capital BDC | CCAP | 31. oct 2024 | 18.19 | -0.44 |
Crescent Energy | CRGY | 31. oct 2024 | 12.43 | -0.08 |
Cresud A ADR | CRESY | 31. oct 2024 | 9.49 | -1.66 |
Crexendo | CXDO | 31. oct 2024 | 5.52 | -3.33 |
CRH | CRH | 31. oct 2024 | 95.43 | -0.55 |
Cricut A | CRCT | 31. oct 2024 | 6.58 | -2.66 |
Crinetics Pharmaceuticals | CRNX | 31. oct 2024 | 55.96 | +0.36 |
CRISPR Therapeutics | CRSP | 31. oct 2024 | 46.39 | -3.21 |
Criteo ADR | CRTO | 31. oct 2024 | 33.68 | +0.27 |
Critical Metals | CRML | 31. oct 2024 | 6.18 | -4.48 |
Crocs | CROX | 31. oct 2024 | 107.82 | -1.08 |
Cronos Group | CRON | 31. oct 2024 | 2.09 | -0.95 |
Cross Country Healthcare | CCRN | 31. oct 2024 | 11.41 | -2.48 |
Cross Timbers Royalty Royalty Trust | CRT | 31. oct 2024 | 10.15 | -3.33 |
CrossAmerica Partners LP Unit | CAPL | 31. oct 2024 | 21.34 | -0.33 |
CrossFirst Bankshares | CFB | 31. oct 2024 | 15.70 | -2.91 |
CrowdStrike A | CRWD | 31. oct 2024 | 296.87 | -3.44 |
Crown Castle | CCI | 31. oct 2024 | 107.49 | -0.30 |
Crown Crafts | CRWS | 31. oct 2024 | 4.54 | -1.94 |
Crown ElectroKinetics | CRKN | 31. oct 2024 | 0.96 | +8.24 |
Crown Holdings | CCK | 31. oct 2024 | 93.55 | -2.23 |
Crown LNG | CGBS | 31. oct 2024 | 0.27 | -6.27 |
Cryo-Cell International | CCEL | 31. oct 2024 | 7.34 | +0.41 |
CryoPort | CYRX | 31. oct 2024 | 6.66 | -2.20 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.